58–87 day lead time · AUC-ROC 0.91 · 65,000+ tiles

Access tiers

From open research access to full enterprise deployment. Every tier includes the 8-layer governance stack, audit chains, SHAP explainability, and HITL sign-off.

Research
Free
Open access for academic & NGO use
  • Access to 500 representative tiles
  • 5 priority pathogens
  • 48-month historical data
  • SHAP feature attribution
  • Governance audit trail
  • Data delayed 30 days
  • Community support
Request access

For academic institutions, independent researchers, and registered NGOs.

Most popular
Agency
Contact us
Per-country or regional pricing
  • Full 65,000+ tile global coverage
  • Real-time risk scores (< 24h lag)
  • REST API with JWT auth
  • HITL sign-off workflows
  • DHIS2 & WHO GOARN integration
  • GDPR / HIPAA data residency options
  • Dedicated onboarding & SLA
Request pilot

For national and sub-national public health agencies, ministries of health, and WHO member state partners.

Global
Enterprise
Custom SLA · on-prem available
  • Everything in Agency
  • On-premises or air-gapped deployment
  • Custom pathogen expansion
  • White-label dashboard option
  • Direct model access (XGBoost + SHAP)
  • MLflow experiment tracking
  • Executive briefing reports
Talk to us

For WHO, World Bank, multilateral agencies, and sovereign health data programmes.

Not sure which tier fits?
We work with agencies of every size. Tell us about your use case and we'll recommend the right access level.
hello@aqtabio.org

Frequently asked questions

What does 'no PHI' mean in practice?
AqtaBio uses population-level ecological indicators only, no patient records, no individual-level data. All features are derived from open environmental, climatic, and biodiversity datasets. This means no HIPAA/GDPR Article 9 consent requirements for the core data layer.
How does data residency work?
By default, EU customers are served from AWS eu-west-1 (Ireland). US government customers can elect us-east-1. On-premises deployment (Global tier) removes cloud dependency entirely.
What is the 53-day lead time claim?
In retrospective analysis, AqtaBio's model assigned Hubei province a risk score of 0.82 in November 2019, 53 days before WHO notification on 31 December 2019. This is documented in our Proof of Concept page with full methodology.
Can we pilot before committing?
Yes. Agency tier pilots are available at no cost for 90 days for qualified public health agencies. Contact hello@aqtabio.org with your institution name and use case.

© 2026 Aqta Technologies Limited · Dublin, Ireland

Privacy·Terms·Government Partners·Dashboard